Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$9.95 - $12.27 $17,322 - $21,362
-1,741 Reduced 30.35%
3,995 $42,000
Q1 2022

May 04, 2022

BUY
$9.81 - $15.4 $56,270 - $88,334
5,736 New
5,736 $62,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $171,123 - $195,403
-12,915 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $56,289 - $70,091
-4,340 Reduced 25.15%
12,915 $185,000
Q1 2021

May 06, 2021

SELL
$13.59 - $18.54 $31,963 - $43,606
-2,352 Reduced 12.0%
17,255 $241,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $280,380 - $367,435
19,607 New
19,607 $368,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.